Compounds > cladribine
Page last updated: 2024-08-22

cladribine and Erythroderma, Sezary

cladribine has been researched along with Erythroderma, Sezary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E; Tallman, MS1
Hellmann, A; Lewandowski, K; Pawlik, H; Siedlewicz, A; Zaucha, JM1
Bouwhuis, SA; el-Azhary, RA; Gibson, LE; Habermann, TM; McEvoy, MT; Pittelkow, MR; Witzig, TE1

Trials

1 trial(s) available for cladribine and Erythroderma, Sezary

ArticleYear
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma.
    Blood, 1996, Feb-01, Volume: 87, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Cladribine; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Opportunistic Infections; Sezary Syndrome; Skin Neoplasms; Treatment Outcome

1996

Other Studies

2 other study(ies) available for cladribine and Erythroderma, Sezary

ArticleYear
2-Chlorodeoxyadenosine treatment in the Sezary syndrome.
    Blood, 1997, Feb-15, Volume: 89, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cladribine; Female; Humans; Infections; Male; Middle Aged; Neutropenia; Sezary Syndrome; Thrombocytopenia; Treatment Failure

1997
Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    International journal of dermatology, 2002, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Survival Rate

2002